AT
Amani Therapeutics, Inc.
SEC filingOther Health Care · New York, NY
Amount raised$31.1Msold at filing
Total offering$31.1M
Investors in the raise2count reported to the SEC
FiledDec 10, 2025first sale Nov 25, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Alice LeeExecutive Officer, Director
-- RTW Holdings VI, LLCPromoter
Executive officers, directors and promoters as listed on the Form D.